Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

David M. Fleischer, Wayne G. Shreffler, Dianne E. Campbell, Todd D. Green, Sara Anvari, Amal Assa’ad, Philippe Bégin, Kirsten Beyer, J. Andrew Bird, Terri Brown‐Whitehorn, Aideen Byrne, Edmond S. Chan, Amarjit Cheema, R. Sharon Chinthrajah, Hey Chong, Carla M. Davis, Lara S. Ford, Rémi Gagnon, Matthew Greenhawt, Jonathan O’B Hourihane, Stacie M. Jones, Edwin Kim, Lars Lange, Bruce J. Lanser, Stephanie A. Leonard, Vera Mahler, Andreas Maronna, Anna Nowak‐Węgrzyn, Roxanne C. Oriel, Michael O’Sullivan, Daniel Petroni, Jacqueline A. Pongracic, Susan L. Prescott, Lynda C. Schneider, Peter Smith, Doris Staab, Gordon L. Sussman, Robert A. Wood, William H. Yang, Romain Lambert, Aurélie Peillon, Timothée Bois, Hugh A. Sampson